A 50-year-old postmenopausal woman presented with a 9-month history of a lump on her left anterior chest wall in the region of the 2nd and 3rd costochondral junction. She reported the mass changed in size and at times felt soft and fluctuant. It intermittently swelled, causing her local discomfort followed by periods of spontaneous regression, which would be accompanied by inflammation localized to the surrounding chest wall. Physical examination revealed a firm mass along the left superior chest wall measuring approximately 6 9 3 cm. It was fixed in position and slightly tender to palpation. She was afebrile. No other joint complaints were reported. She had a history of ovarian cancer diagnosed at age 24 years; the workup for metastatic disease to the bones and solid organs was negative at that time. Her ovarian cancer was treated with whole-abdomen radiation therapy, chemotherapy, and a total abdominal hysterectomy and bilateral salpingooophorectomy. She had no symptoms or signs of metastatic disease in the interim.
History and Physical Examination
A 50-year-old postmenopausal woman presented with a 9-month history of a lump on her left anterior chest wall in the region of the 2nd and 3rd costochondral junction. She reported the mass changed in size and at times felt soft and fluctuant. It intermittently swelled, causing her local discomfort followed by periods of spontaneous regression, which would be accompanied by inflammation localized to the surrounding chest wall. Physical examination revealed a firm mass along the left superior chest wall measuring approximately 6 9 3 cm. It was fixed in position and slightly tender to palpation. She was afebrile. No other joint complaints were reported. She had a history of ovarian cancer diagnosed at age 24 years; the workup for metastatic disease to the bones and solid organs was negative at that time. Her ovarian cancer was treated with whole-abdomen radiation therapy, chemotherapy, and a total abdominal hysterectomy and bilateral salpingooophorectomy. She had no symptoms or signs of metastatic disease in the interim.
Plain radiographs of the chest were noncontributory. CT and MRI of the chest wall were performed (Figs. 1, 2) .
Based on the history, physical examination, and imaging studies, what is the differential diagnosis?
Imaging Interpretation
CT scanning of the chest showed a mixed attenuation mass along the anterior left chest wall involving the second and third costochondral and costosternal regions, measuring approximately 5 9 3 9 3.6 cm. It was unclear by imaging whether the mass was centered in the osseous or soft tissue structures. Areas of somewhat amorphous, coarse calcification were present in the mass (Fig. 1A) . Small focal areas of sclerosis were noted involving the adjacent margins of the sternum and ribs, with no gross destructive changes observed. The more superficial, low-attenuation component of the mass appeared to mildly displace but not invade the overlying pectoralis muscle (Fig. 1B) .
On MRI, the more superficial component of the mass had low signal intensity on coronal T1-weighted images ( Fig. 2A) and fluid signal intensity on the T2-weighted images. The deeper component adjacent to the costosternal junction had low signal intensity on both sequences, consistent with a nodular soft tissue component measuring approximately 4.2 9 1.6 cm. There were no obvious calcifications seen on the MR images. The axial T2-weighted image showed a single fluid-fluid level (Fig. 2B) . On postcontrast imaging, the nonenhancing cystic component Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article. Each author certifies that his or her institution approved the reporting of this case report, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
and an enhancing mural nodule were observed, with adjacent soft tissue enhancement (Fig. 2C ).
Differential Diagnosis
Osteoarthritis of the second and third costochondral and costosternal regions with complex ganglion cyst formation Infection (mycobacterial origin) Crystal deposition disease (gout or calcium hydroxyapatite) Myxoid sarcoma Metastatic disease A CT-guided biopsy and aspiration were performed. Subsequently, the lesion was excised and examined histologically (Fig. 3) .
Based on the history, physical findings, radiology, and histology, what is the diagnosis?
Histopathology Interpretation
Approximately 5 to 6 mL serous fluid was aspirated and submitted. The histologic features were predominantly those of skeletal muscle and fibrofatty tissue with two tiny clusters of malignant epithelial cells with hyperchromatic nuclei forming papillae diagnostic of metastatic well-differentiated adenocarcinoma (Fig. 3A) .
Diagnosis
Metastatic papillary serous adenocarcinoma from ovarian primary.
Discussion and Treatment
At age 24 years, our patient had Stage IIIB disease with contiguous spread to the ovaries, uterus, fallopian tubes, pelvic side wall, peritoneum, bladder, and serosa of the large bowel. Workup for metastatic disease at the time of original diagnosis was negative. She had been considered disease free for a 26-year interval. In view of the remote history of ovarian carcinoma, the biopsy results were consistent with metastatic papillary ovarian carcinoma. Diagnosis was confirmed by a positive immunoassay for CA 125 and CK 7 (Fig. 3B) . Fluid submitted for cytopathologic study showed metastatic papillary serous adenocarcinoma with psammoma bodies consistent with an ovarian primary.
This case is of interest from the perspective of a longterm quiescent malignant disease recurring with an unusual metastatic focus and presenting as a soft tissue lesion centered around the costosternal or sternoclavicular joints. The sternoclavicular and costosternal joints, when symptomatic, are typically the sites of degenerative or arthritic changes. Osteoarthritis, inflammatory arthritis, and gout are common diseases that manifest as costosternal or sternoclavicular pain. These entities are centered at the joint margin and tend to have productive changes, such as osteophyte formation, reactive periostitis, and hyperostosis. These were notably absent in our patient on advanced imaging. A unilateral presentation also would include the differential of septic arthritis, however, this typically would result in a much more rapid onset of joint destruction and disorganization. Clinical features of soft tissue redness and induration were not present. This also would be atypical given the 9-month history of the patient's symptoms. Although myxoid sarcoma was included in the differential diagnosis given the imaging findings, primary bone or cartilage tumors in this region are quite rare. Secondary metastatic lesions also would be quite unusual outside of soft tissue sarcoma primaries or melanoma. The patient's history of increasing and decreasing size of the lesion also seemed inconsistent with neoplastic processes. New diagnoses of ovarian cancer in the US in 2006 were estimated at more than 20,000 [16] . Ninety percent of cancers arise from the surface epithelium having various subtypes, with serous tumors being the most common. The overall survival rate for patients with Stage III malignancy is 21% and between 5% and 8% for patients with Stage IV disease. Ovarian neoplasms are quite deadly, with 60% to 65% of patients currently presenting with Stage III malignancy [16] .
Ovarian neoplasms metastasize to intraperitoneal solid organs [9] , colon [18] , bladder [17] , breast [8, 11, 14] , skin [5] , brain [4] , and supradiaphragmatic lymph nodes and organs [13] . Metastases to bone are distinctly uncommon, with the prevalence reported as 1.6% [1-3, 6, 7, 15] , with the most frequent subtype being papillary adenocarcinoma [7] .
Although metastasis to the skin surface and subcutaneous tissues has been estimated to occur in just greater than 3% of patients with recurrent ovarian cancer [5, 12] , involvement of deep soft tissues and muscles is much less common. Osseous and soft tissue involvement is thought to occur either by direct extension from paraaortic or iliac lymph nodes, or by lymphatic or hematogenous spread [7, 12] . Hematogenous or lymphatic spread may have occurred in our patient. Chemotherapy and radiotherapy are used for treatment of local and widespread metastatic disease, while resection of solitary metastases can be performed.
We found one published case of ovarian carcinoma with metastasis in the region of the sternum and costae [10] . The mean interval between diagnosis and the appearance of osseous metastasis was reported as 7 years 7 months. Our patient's interval from original disease to current presentation was substantially longer (26 years). In addition, it appears the costosternal joints were involved via spread from the adjacent muscles/soft tissues.
After biopsy, the whole-body bone scan showed a solitary focus of increased uptake involving the left anterior chest wall just inferior to the left sternoclavicular joint. PET/CT scans showed a heterogeneous focus of intense fluorodeoxyglucose (FDG) uptake (maximal standardized uptake value, 12.4 g/mL) in the left upper anterior chest wall, located just lateral to the manubrium. Our patient initially was treated with chemotherapy with poor response. Subsequently, the patient underwent radical resection of the metastatic soft tissue mass and anterior chest wall with reconstruction using methylmethacrylate and GORE-TEX 1 patches (Fig. 4) . Final pathologic analysis of the surgical specimen showed metastatic papillary adenocarcinoma involving the soft tissues adjacent to the mass, the second and third left ribs, their respective intercostal muscles, and portions of the pectoralis major and minor muscles. Radiation was administered postoperatively. Two and one-half years after surgery, the patient is disease free and has full functional use of her left upper extremity.
